ArticleAbdominal radiology (New York)2026
Patient perspectives on follow-up CT scans after treatment for renal cell carcinoma (RCC): a cross-sectional questionnaire study.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis cross-sectional questionnaire study aims to gain insight into health-related quality of life (HRQoL) and patients' perspectives on reducing the follow-up frequency of follow-up CTs after curative treatment for adult patients with renal cell carcinoma (RCC).
methodsThis prospective single-center study was conducted between June 15, 2023 and April 9, 2025. Adult patients with histologically confirmed de novo RCC who underwent curative surgery (radical/partial nephrectomy) or a type of tumor ablation (cryoablation/MWA/RFA) and were scheduled for follow-up CT, were invited to complete a self-administered questionnaire. HRQoL was assessed using the validated by EuroQol Research Foundation EQ-5D-5 L questionnaire. Patient perspective on follow-up was explored through a self-developed questionnaire consisting of eight closed-ended and two open-ended questions.
resultsFifty patients completed the questionnaire. The overall response rate of the EQ-5D-5 L questionnaire was 98.0%, with no health state problems (level 1) being the most frequently selected answer (78.0%). The response rate of the self-developed questionnaire was 97.0%. In the closed-ended question, most patients reported that follow-up CTs gives extra reassurance (84.0%). Patients were generally satisfied (79.6%) with the current number of follow-up CTs. A potential reduction in scanning frequency was often perceived negatively, 68.0% find it unpleasant and 64.0% would feel less safe. In the open-ended questions, 42.0% mentioned increased uncertainty as a disadvantage of reduced imaging. No significant differences were found between early and late follow-up groups (p > 0.05).
conclusionThis study shows that although reduced follow-up imaging may be clinically safe, successful implementation will require clear communication, expectation management and shared decision-making to address patients' emotional and psychological needs. TAKE HOME MESSAGE: Follow-up CT scans offer patients a sense of security. Reducing the frequency requires careful communication and shared decision-making to minimize anxiety.
Indexed as
Identifiers
41364220What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.